Form 4: Curis Inc. Director Hohneker Receives Stock Option Grant Following Shareholder Approval

Director John Hohneker received a stock option grant for 4,250 shares of Curis Inc. following shareholder approval of the Fifth Amended and Restated 2010 Stock Incentive Plan.

Summary

• John Hohneker, a director of Curis Inc., received a stock option grant on May 21, 2024.
• The grant is for 4,250 shares of Curis Inc. common stock.
• The exercise price of the option is $11.62.
• The option vests on January 20, 2025, and expires on January 19, 2034.
• The grant was contingent upon shareholder approval of Curis's Fifth Amended and Restated 2010 Stock Incentive Plan, which was obtained on May 21, 2024.

Sentiment

Score: 7

Explanation: The document indicates a standard executive compensation practice, suggesting a stable and well-governed company. The shareholder approval further reinforces positive sentiment.

Positives

• The stock option grant aligns the director's interests with those of the shareholders.
• The vesting schedule encourages long-term commitment from the director.
• Shareholder approval of the Fifth Amended and Restated 2010 Stock Incentive Plan indicates support for the company's compensation strategy.

Future Outlook

Not explicitly stated, but the option grant suggests an expectation of future value creation.

Industry Context

Stock option grants are a common form of executive compensation in the biotechnology industry, aligning management's interests with those of shareholders.

Comparison to Industry Standards

• Stock option grants are a standard component of compensation packages for directors in publicly traded companies, particularly in the biotech sector.
• The size of the grant (4,250 shares) would need to be compared to grants given to directors at comparable companies to assess its relative value.
• Companies like Amgen, Gilead, and Biogen often use stock options as part of their director compensation packages.

Stakeholder Impact

• Shareholders benefit from aligning director incentives with company performance.
• Employees may be indirectly impacted by the director's increased motivation to improve company value.

Key Dates